A better understanding of the proteomic profile after bipolar disorder (BD) and
schizophrenia (SCZ) treatment, through monitoring its progression, may assist
the development of novel therapeutic strategies with the ability to reduce or
control possible side effects. In this study, proteomics analysi...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606)